Indole-3-carbinol in vitro antiviral activity against sars-cov-2 virus and in vivo toxicity

HIGHLIGHTS

• who: Federica Centofanti from the (UNIVERSITY) have published the paper: Indole-3-carbinol in vitro antiviral activity against SARS-Cov-2 virus and in vivo toxicity, in the Journal: (JOURNAL) of 28/09/2022
• what: In fact, this analysis showed a different tolerability dose in males and females to be considered for any future clinical trials in which I3C will be used as an antiviral compound. This study demonstrated for the first time that I3C has an anti-SARS-CoV-2 effect independently of the time of treatment in respect to the time of viral . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.